Oticon Intent vs Vivtone Xpure Hearing Aid

The Oticon Intent is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898 and earning an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #4 among 39 prescription hearing aids tested, within the top 8% of its category. In our testing, the Intent demonstrates notable strengths in speech performance, scoring 0.54 points above the category average for speech in quiet and a substantial 0.95 points above average for speech in noise. Music streaming is a particular highlight, measuring 1.24 points above the category average with a strong 4.0/5 score. Feedback handling is excellent at 5.0/5, slightly exceeding the already-high category average. The primary limitation revealed in our testing is own-voice comfort, which scores 1.3/5—a low absolute score that falls 1.40 points below the category average. Users sensitive to the sound of their own voice may find this characteristic noticeable. This is a common trade-off in devices optimized for speech audibility. The Oticon Intent is well-suited for users prioritizing speech understanding across varied listening environments and high-quality audio streaming. It has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. Shoppers in this premium price tier may also consider the Phonak Sphere Infinio (#2) or the lower-priced Oticon Zeal, which offers strong performance at a reduced cost.

The Vivtone Xpure is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. This places it in the lower tier of the OTC category, ranking #57 of 65 devices tested. The Xpure demonstrates a notably uneven performance profile. Its standout strength is music streaming, scoring an excellent 4.4/5—a remarkable 2.48 points above the category average. This makes it one of the better choices for users who prioritize audio entertainment through their hearing aids. Speech in quiet performs just slightly above category average at 2.9/5, though this remains mixed in absolute terms. However, the device shows significant weaknesses in several areas. Own-voice comfort scores a low 0.8/5, falling 1.71 points below the category average—a notable concern for users sensitive to how their own voice sounds. Speech in noise at 1.2/5 sits below the category average, and feedback handling, while solid at 3.3/5, still falls 1.24 points below what typical OTC devices achieve. The Xpure improves meaningfully with professional tuning, jumping from a normalized Initial Score of 3.0/5 to a Tuned Score of 3.5/5. Shoppers prioritizing music streaming may find value here, but those seeking balanced speech performance or natural own-voice quality should consider alternatives like the Linner Nova Earbud or Nuheara IQBuds Max, which offer higher overall scores at lower prices.